Skip to main content
Erschienen in: Arthritis Research & Therapy 2/2001

01.11.2001 | Review

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

verfasst von: Martinus AM van Boekel, Erik R Vossenaar, Frank HJ van den Hoogen, Walther J van Venrooij

Erschienen in: Arthritis Research & Therapy | Ausgabe 2/2001

Einloggen, um Zugang zu erhalten

Abstract

The diagnosis of rheumatoid arthritis (RA) is primarily based on clinical symptoms, so it is often difficult to diagnose RA in very early stages of the disease. A disease-specific autoantibody that could be used as a serological marker would therefore be very useful. Most autoimmune diseases are characterized by a polyclonal B-cell response targeting multiple autoantigens. These immune responses are often not specific for a single disease. In this review, the most important autoantibody/autoantigen systems associated with RA are described and their utility as a diagnostic and prognostic tool, including their specificity, sensitivity and practical application, is discussed. We conclude that, at present, the antibody response directed to citrullinated antigens has the most valuable diagnostic and prognostic potential for RA.
Literatur
1.
Zurück zum Zitat Gabriel SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001, 27: 269-281.PubMedCrossRef Gabriel SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001, 27: 269-281.PubMedCrossRef
2.
Zurück zum Zitat Mageed RA: The RF antigen. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-27. section B1.1 Mageed RA: The RF antigen. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-27. section B1.1
3.
Zurück zum Zitat Smolen JS: Autoantibodies in rheumatoid arthritis. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-18. section C1.1 Smolen JS: Autoantibodies in rheumatoid arthritis. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-18. section C1.1
4.
Zurück zum Zitat Sutton B, Corper A, Bonagura V, Taussig M: The structure and origin of rheumatoid factors. Immunol Today. 2000, 4: 177-183. 10.1016/S0167-5699(00)01589-9.CrossRef Sutton B, Corper A, Bonagura V, Taussig M: The structure and origin of rheumatoid factors. Immunol Today. 2000, 4: 177-183. 10.1016/S0167-5699(00)01589-9.CrossRef
5.
Zurück zum Zitat Pai S, Pai L, Birkenfeldt R: Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol. 1998, 27: 252-256. 10.1080/030097498442352.PubMedCrossRef Pai S, Pai L, Birkenfeldt R: Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol. 1998, 27: 252-256. 10.1080/030097498442352.PubMedCrossRef
6.
Zurück zum Zitat Hoessien DA, Jonsson T, Davies E, Scott DL: Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Rheumatol. 1997, 24: 2119-2122. Hoessien DA, Jonsson T, Davies E, Scott DL: Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Rheumatol. 1997, 24: 2119-2122.
7.
Zurück zum Zitat Jonsson T, Steinsson K, Jonsson H, Geirsson AJ, Thorsteinsson J, Valdimarsson H: Combined elevation of IgM and IgA rheumatoid factor has a high diagnostic specificity for rheumatoid arthritis. Rheum Int. 1998, 18: 119-122. 10.1007/s002960050069.CrossRef Jonsson T, Steinsson K, Jonsson H, Geirsson AJ, Thorsteinsson J, Valdimarsson H: Combined elevation of IgM and IgA rheumatoid factor has a high diagnostic specificity for rheumatoid arthritis. Rheum Int. 1998, 18: 119-122. 10.1007/s002960050069.CrossRef
8.
Zurück zum Zitat Swedler W, Wallman J, Froelich CJ, Teodorescu M: Routine measurement of IgM, IgG and IgA rheumatoid factors: High sensitivity, specificity and predictive value for rheumatoid arthritis. J Rheumatol. 1997, 24: 1037-1044.PubMed Swedler W, Wallman J, Froelich CJ, Teodorescu M: Routine measurement of IgM, IgG and IgA rheumatoid factors: High sensitivity, specificity and predictive value for rheumatoid arthritis. J Rheumatol. 1997, 24: 1037-1044.PubMed
9.
Zurück zum Zitat Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen JS: Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 1989, 32: 1515-1520.PubMedCrossRef Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen JS: Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 1989, 32: 1515-1520.PubMedCrossRef
10.
Zurück zum Zitat Steiner G, Hartmuth K, Skriner K, Maurer FI, Sinski A, Thalmann E, Hassfeld W, Barta A, Smolen JS: Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest. 1992, 90: 1061-1066.PubMedPubMedCentralCrossRef Steiner G, Hartmuth K, Skriner K, Maurer FI, Sinski A, Thalmann E, Hassfeld W, Barta A, Smolen JS: Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest. 1992, 90: 1061-1066.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS: Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol. 1993, 32: 199-203.PubMedCrossRef Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS: Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol. 1993, 32: 199-203.PubMedCrossRef
12.
Zurück zum Zitat Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G: Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest. 1997, 100: 127-135.PubMedPubMedCentralCrossRef Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G: Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest. 1997, 100: 127-135.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Menard HA, El-Amine M: The calpain–calpastatin system in rheumatoid arthritis. Immunol Today. 1996, 17: 545-547. 10.1016/S0167-5699(96)30064-9.PubMedCrossRef Menard HA, El-Amine M: The calpain–calpastatin system in rheumatoid arthritis. Immunol Today. 1996, 17: 545-547. 10.1016/S0167-5699(96)30064-9.PubMedCrossRef
14.
Zurück zum Zitat Yamamoto S, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T: Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum. 1992, 35: 1309-1317.PubMedCrossRef Yamamoto S, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T: Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum. 1992, 35: 1309-1317.PubMedCrossRef
15.
Zurück zum Zitat Szomor Z, Shimizu K, Fujimori Y, Yamamoto S, Yamamuro T: Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice. Ann Rheum Dis. 1995, 54: 477-483.PubMedPubMedCentralCrossRef Szomor Z, Shimizu K, Fujimori Y, Yamamoto S, Yamamuro T: Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice. Ann Rheum Dis. 1995, 54: 477-483.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Despres N, Talbot G, Plouffe B, Boire G, Menard HA: Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest. 1995, 95: 1891-1896.PubMedPubMedCentralCrossRef Despres N, Talbot G, Plouffe B, Boire G, Menard HA: Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest. 1995, 95: 1891-1896.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumura M, Fujii T, Yoshizawa T, Suzuki K, Akizuki M: Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA. 1995, 92: 7267-7271.PubMedPubMedCentralCrossRef Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumura M, Fujii T, Yoshizawa T, Suzuki K, Akizuki M: Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA. 1995, 92: 7267-7271.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Lackner KJ, Schlosser U, Lang B, Schmitz G: Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br J Rheumatol. 1998, 37: 1164-1171. 10.1093/rheumatology/37.11.1164.PubMedCrossRef Lackner KJ, Schlosser U, Lang B, Schmitz G: Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br J Rheumatol. 1998, 37: 1164-1171. 10.1093/rheumatology/37.11.1164.PubMedCrossRef
19.
Zurück zum Zitat Rönnelid J, Lysholm J, Engstrom LA, Klareskog L, Heyman B: Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994, 37: 1023-1029.PubMedCrossRef Rönnelid J, Lysholm J, Engstrom LA, Klareskog L, Heyman B: Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994, 37: 1023-1029.PubMedCrossRef
20.
Zurück zum Zitat Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ: Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 1989, 32: 1087-1092.PubMedCrossRef Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ: Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 1989, 32: 1087-1092.PubMedCrossRef
21.
Zurück zum Zitat Kim W-U, Yoo W-H, Park W, Kang Y-M, Kim S-I, Park J-H, Lee S-S, Joo Y-S, Min J-K, Hong Y-S, Lee S-H, Park S-H, Cho C-S, Kim H-Y: IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol. 2000, 27: 575-581.PubMed Kim W-U, Yoo W-H, Park W, Kang Y-M, Kim S-I, Park J-H, Lee S-S, Joo Y-S, Min J-K, Hong Y-S, Lee S-H, Park S-H, Cho C-S, Kim H-Y: IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol. 2000, 27: 575-581.PubMed
22.
Zurück zum Zitat Reid KB: Complete amino sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem J. 1979, 179: 367-371.PubMedPubMedCentralCrossRef Reid KB: Complete amino sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem J. 1979, 179: 367-371.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Atta MS, Lim KL, Ala'Aldeen DA, Powell RJ, Todd I: Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosis. Ann Rheum Dis. 1995, 54: 117-124.PubMedPubMedCentralCrossRef Atta MS, Lim KL, Ala'Aldeen DA, Powell RJ, Todd I: Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosis. Ann Rheum Dis. 1995, 54: 117-124.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Charles PJ, Maini RN: Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritis. Adv Exp Med Biol. 1993, 336: 367-370.PubMedCrossRef Charles PJ, Maini RN: Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritis. Adv Exp Med Biol. 1993, 336: 367-370.PubMedCrossRef
25.
Zurück zum Zitat Schnabel A, Hauschild S, Gross WL: Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol. 1996, 109: 201-206.PubMedCrossRef Schnabel A, Hauschild S, Gross WL: Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol. 1996, 109: 201-206.PubMedCrossRef
26.
Zurück zum Zitat Kallenberg CG, Mulder AH, Tervaert JW: Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992, 93: 675-682.PubMedCrossRef Kallenberg CG, Mulder AH, Tervaert JW: Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992, 93: 675-682.PubMedCrossRef
27.
Zurück zum Zitat Mulder AH, Horst G, van-Leeuwen MA, Limburg PC, Kallenberg CG: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum. 1993, 36: 1054-1060.PubMedCrossRef Mulder AH, Horst G, van-Leeuwen MA, Limburg PC, Kallenberg CG: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum. 1993, 36: 1054-1060.PubMedCrossRef
28.
Zurück zum Zitat Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K: Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol. 1998, 25: 703-709.PubMed Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K: Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol. 1998, 25: 703-709.PubMed
29.
Zurück zum Zitat Morris V, Mackworth-Young C: Antiphospholipid antibodies: clinical aspects. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-14. section C2.5 Morris V, Mackworth-Young C: Antiphospholipid antibodies: clinical aspects. In Manual of Biological Markers of Disease. Edited by van Venrooij WJ & Maini RN. Dordrecht: Kluwer Academic Publishers;. 1996, 1-14. section C2.5
30.
Zurück zum Zitat Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, Benali K, Eliaou JF, Kahn MF, Sany J, Meyer O: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol. 1999, 26: 7-13.PubMed Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, Benali K, Eliaou JF, Kahn MF, Sany J, Meyer O: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol. 1999, 26: 7-13.PubMed
31.
Zurück zum Zitat Despres N, Boire G, Lopez-Longo FJ, Menard HA: The Sa system: a novel antigen–antibody system specific for rheumatoid arthritis. J Rheumatol. 1994, 21: 1027-1033.PubMed Despres N, Boire G, Lopez-Longo FJ, Menard HA: The Sa system: a novel antigen–antibody system specific for rheumatoid arthritis. J Rheumatol. 1994, 21: 1027-1033.PubMed
32.
Zurück zum Zitat Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Ménard HA, Zhou ZJ, Palosuo T, van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR, El-Gabalawy HS: Rheumatoid arthritis associated autoan-tibodies in patients with synovitis of recent onset. Arthritis Res. 2000, 2: 236-243. 10.1186/ar93.PubMedPubMedCentralCrossRef Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Ménard HA, Zhou ZJ, Palosuo T, van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR, El-Gabalawy HS: Rheumatoid arthritis associated autoan-tibodies in patients with synovitis of recent onset. Arthritis Res. 2000, 2: 236-243. 10.1186/ar93.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Menard HA, Boire G, Lopez-Longo FJ, Lapointe S, Larose A: Insights into rheumatoid arthritis derived from the Sa immune system. ArthritisRes. 2000, 2: 429-432. 10.1186/ar122. Menard HA, Boire G, Lopez-Longo FJ, Lapointe S, Larose A: Insights into rheumatoid arthritis derived from the Sa immune system. ArthritisRes. 2000, 2: 429-432. 10.1186/ar122.
34.
Zurück zum Zitat Saulot V, Yon G, Vittecoq O, Charlionnet R, Machour N, Lange C, Marvin L, Gilbert D, Le Loet X: Sa, Alpha-enolase and rheumatoid arthritis [abstract]. Arthritis Rheum. 2000, 43(suppl): S68- Saulot V, Yon G, Vittecoq O, Charlionnet R, Machour N, Lange C, Marvin L, Gilbert D, Le Loet X: Sa, Alpha-enolase and rheumatoid arthritis [abstract]. Arthritis Rheum. 2000, 43(suppl): S68-
35.
Zurück zum Zitat Bläβ S, Specker C, Lakomek HJ, Schneider EM, Schwochau M: Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies. Ann Rheum Dis. 1995, 54: 355-360.CrossRef Bläβ S, Specker C, Lakomek HJ, Schneider EM, Schwochau M: Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies. Ann Rheum Dis. 1995, 54: 355-360.CrossRef
36.
Zurück zum Zitat Bläβ S, Union A, Raymackers J, Schumann F, Ungethüm U, Müller-Steinbach S, De Keyser F, Engel J-M, Burmester GR: The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 761-771. 10.1002/1529-0131(200104)44:4<761::AID-ANR132>3.3.CO;2-J.CrossRef Bläβ S, Union A, Raymackers J, Schumann F, Ungethüm U, Müller-Steinbach S, De Keyser F, Engel J-M, Burmester GR: The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 761-771. 10.1002/1529-0131(200104)44:4<761::AID-ANR132>3.3.CO;2-J.CrossRef
37.
Zurück zum Zitat Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley PH, Soh C, Staines NA, Pappin DJC, Berlo SE, van Eden W, van der Zee R, Lanchbury JS, Panayi GS: The human endoplasmatic reticulum molecular chaperone BiP is an autoanti-gen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001, 166: 1492-1498.PubMedCrossRef Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley PH, Soh C, Staines NA, Pappin DJC, Berlo SE, van Eden W, van der Zee R, Lanchbury JS, Panayi GS: The human endoplasmatic reticulum molecular chaperone BiP is an autoanti-gen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001, 166: 1492-1498.PubMedCrossRef
38.
Zurück zum Zitat Bläβ S, Haferkamp C, Specker C, Schwochau M, Schneider M, Schneider EM: Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen. Ann Rheum Dis. 1997, 56: 317-322.CrossRef Bläβ S, Haferkamp C, Specker C, Schwochau M, Schneider M, Schneider EM: Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen. Ann Rheum Dis. 1997, 56: 317-322.CrossRef
39.
Zurück zum Zitat Bläβ S, Meier C, Vohr HW, Schwochau M, Specker C, Burmester GR: The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis. 1998, 57: 220-225.CrossRef Bläβ S, Meier C, Vohr HW, Schwochau M, Specker C, Burmester GR: The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis. 1998, 57: 220-225.CrossRef
40.
Zurück zum Zitat Schaller M, Burton DR, Ditzel HJ: Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001, 2: 746-753. 10.1038/90696.PubMedCrossRef Schaller M, Burton DR, Ditzel HJ: Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001, 2: 746-753. 10.1038/90696.PubMedCrossRef
41.
Zurück zum Zitat Nienhuis RLF, Mandena EA: A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis. 1964, 23: 302-305.PubMedPubMedCentralCrossRef Nienhuis RLF, Mandena EA: A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis. 1964, 23: 302-305.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Hoet RM, Van Venrooij WJ: The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In Rheumatoid Arthritis. Edited by Smolen J, Kalden J & Maini RN. Berlin: Springer Verlag;. 1992, 299-318. Hoet RM, Van Venrooij WJ: The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In Rheumatoid Arthritis. Edited by Smolen J, Kalden J & Maini RN. Berlin: Springer Verlag;. 1992, 299-318.
44.
Zurück zum Zitat Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1995, 95: 2672-2679.PubMedPubMedCentralCrossRef Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1995, 95: 2672-2679.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Gan SQ, McBride OW, Idler WW, Nedialka M, Steinert PM: Organization, structure, and polymorphisms of the human profillagrin gene. Biochemistry. 1990, 29: 9423-9440.CrossRef Gan SQ, McBride OW, Idler WW, Nedialka M, Steinert PM: Organization, structure, and polymorphisms of the human profillagrin gene. Biochemistry. 1990, 29: 9423-9440.CrossRef
46.
Zurück zum Zitat Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281.PubMedPubMedCentralCrossRef Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessière C, Jolivet-Reynaud C, Jolivet M, Serre G: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999, 162: 585-594.PubMed Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessière C, Jolivet-Reynaud C, Jolivet M, Serre G: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999, 162: 585-594.PubMed
48.
Zurück zum Zitat Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux JJ, Cantagrel A, Fournie B, Mazieres B, Serre G: Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol. 1998, 25: 838-846.PubMed Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux JJ, Cantagrel A, Fournie B, Mazieres B, Serre G: Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol. 1998, 25: 838-846.PubMed
49.
Zurück zum Zitat Slack SL, Mannik M, Dale BA: Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol. 1998, 25: 847-851.PubMed Slack SL, Mannik M, Dale BA: Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol. 1998, 25: 847-851.PubMed
50.
Zurück zum Zitat Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, Heikkila R, Nykanen M, von Essen R: Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allegy Immunol. 1998, 115: 294-302. 10.1159/000069460.CrossRef Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, Heikkila R, Nykanen M, von Essen R: Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allegy Immunol. 1998, 115: 294-302. 10.1159/000069460.CrossRef
51.
Zurück zum Zitat Paimela L, Palosuo T, Aho K, Lukka M, Kurki P, Leirisalo-Repo M, von Essen R: Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Disease. 2001, 60: 32-35. 10.1136/ard.60.1.32.CrossRef Paimela L, Palosuo T, Aho K, Lukka M, Kurki P, Leirisalo-Repo M, von Essen R: Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Disease. 2001, 60: 32-35. 10.1136/ard.60.1.32.CrossRef
52.
Zurück zum Zitat Aho K, Palosuo T, Lukka M, Kurki P, Isomaki H, Kautiainen H, von Essen R: Anti-filaggrin antibodies in recent-onset arthritis. Scand J Rheumatol. 1999, 28: 113-116. 10.1080/030097499442586.PubMedCrossRef Aho K, Palosuo T, Lukka M, Kurki P, Isomaki H, Kautiainen H, von Essen R: Anti-filaggrin antibodies in recent-onset arthritis. Scand J Rheumatol. 1999, 28: 113-116. 10.1080/030097499442586.PubMedCrossRef
53.
Zurück zum Zitat Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity-purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 882-887.PubMedPubMedCentral Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity-purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 882-887.PubMedPubMedCentral
54.
Zurück zum Zitat Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R: Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000, 27: 2743-2746.PubMed Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R: Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000, 27: 2743-2746.PubMed
55.
Zurück zum Zitat Forslind K, Vincent C, Serre G, Svensson B: Antifilaggrin autoantibodies in early rheumatoid arthritis. Scand J Rheumatol. 2000, 29: 320-322. 10.1080/030097400447714.PubMedCrossRef Forslind K, Vincent C, Serre G, Svensson B: Antifilaggrin autoantibodies in early rheumatoid arthritis. Scand J Rheumatol. 2000, 29: 320-322. 10.1080/030097400447714.PubMedCrossRef
56.
Zurück zum Zitat Schellekens GA, Visser H, de Jong BAW, van den Hoogen FH, Hazes JM, Breedeveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.PubMedCrossRef Schellekens GA, Visser H, de Jong BAW, van den Hoogen FH, Hazes JM, Breedeveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.PubMedCrossRef
57.
Zurück zum Zitat Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R: Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem. 2001, 47: 1089-1093.PubMed Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R: Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem. 2001, 47: 1089-1093.PubMed
58.
Zurück zum Zitat Vencovský J, Šedová L, Machácek S, Kafková J, Gatterová J, Pešáková V, Ruzicková S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2001, Vencovský J, Šedová L, Machácek S, Kafková J, Gatterová J, Pešáková V, Ruzicková S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2001,
59.
Zurück zum Zitat van Jaarsveld CHM, ter Borg EJ, Jacobs JWG, Schellekens GA, Gmelig-Meyling FHJ, van Booma-Frankfort C, de Jong BAW, van Venrooij WJ, Bijlsma JWJ: The prognostic value of the antiperi-nuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol. 1999, 17: 689-697.PubMed van Jaarsveld CHM, ter Borg EJ, Jacobs JWG, Schellekens GA, Gmelig-Meyling FHJ, van Booma-Frankfort C, de Jong BAW, van Venrooij WJ, Bijlsma JWJ: The prognostic value of the antiperi-nuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol. 1999, 17: 689-697.PubMed
60.
Zurück zum Zitat Kroot EJJA, de Jong BAW, van Leeuwen MA, Swinkels H, van den Hoogen FHJ, van't Hof M, van de Putte LBA, van Rijswijk MH, van Venrooij WJ, van Riel PLCM: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-1835. 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6.PubMedCrossRef Kroot EJJA, de Jong BAW, van Leeuwen MA, Swinkels H, van den Hoogen FHJ, van't Hof M, van de Putte LBA, van Rijswijk MH, van Venrooij WJ, van Riel PLCM: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-1835. 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6.PubMedCrossRef
61.
Zurück zum Zitat Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW: How to diagnose rheumatoid arthritis early? A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2001, Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW: How to diagnose rheumatoid arthritis early? A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2001,
62.
Zurück zum Zitat Lapointe E, Déry U, Vaillanciurt F, Ménard HA: Rheumatoid sera potentially recognize all citrullinated proteins [abstract]. Arthritis Rheum. 1999, 42: S86- Lapointe E, Déry U, Vaillanciurt F, Ménard HA: Rheumatoid sera potentially recognize all citrullinated proteins [abstract]. Arthritis Rheum. 1999, 42: S86-
63.
Zurück zum Zitat Masson-Bessière C, Sebbag M, Durieux JJ, Norgueira L, Vincent C, Girbal-Neuhauser E, Durroux R, Cantagrel A, Serre G: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol. 2000, 119: 544-552. 10.1046/j.1365-2249.2000.01171.x.PubMedPubMedCentralCrossRef Masson-Bessière C, Sebbag M, Durieux JJ, Norgueira L, Vincent C, Girbal-Neuhauser E, Durroux R, Cantagrel A, Serre G: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol. 2000, 119: 544-552. 10.1046/j.1365-2249.2000.01171.x.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Reparon-Schuijt CC, van Esch WJE, van Kooten C, Schellekens GA, de Jong BAW, van Venrooij WJ, Breedveld FC, Verweij CL: Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 41-47. 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0.PubMedCrossRef Reparon-Schuijt CC, van Esch WJE, van Kooten C, Schellekens GA, de Jong BAW, van Venrooij WJ, Breedveld FC, Verweij CL: Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 41-47. 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0.PubMedCrossRef
65.
Zurück zum Zitat Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α and β-chains of fibrin. J Immunol. 2001, 166: 4177-4184.PubMedCrossRef Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α and β-chains of fibrin. J Immunol. 2001, 166: 4177-4184.PubMedCrossRef
66.
Zurück zum Zitat Serre G: Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Joint Bone Spine. 2001, 68: 103-105. 10.1016/S1297-319X(01)00259-7.PubMedCrossRef Serre G: Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Joint Bone Spine. 2001, 68: 103-105. 10.1016/S1297-319X(01)00259-7.PubMedCrossRef
67.
Zurück zum Zitat Smolen JS, Steiner G: Are autoantibodies active players or epiphenomena?. Curr Opin Rheumatol. 1998, 10: 201-206.PubMedCrossRef Smolen JS, Steiner G: Are autoantibodies active players or epiphenomena?. Curr Opin Rheumatol. 1998, 10: 201-206.PubMedCrossRef
68.
Zurück zum Zitat Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, Haim T, Kahn MF, Chatellier G: Diagnostic value of anti-RA33 antibody, antikeratin antibody, perinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol. 1996, 35: 620-624.PubMedCrossRef Cordonnier C, Meyer O, Palazzo E, de Bandt M, Elias A, Nicaise P, Haim T, Kahn MF, Chatellier G: Diagnostic value of anti-RA33 antibody, antikeratin antibody, perinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol. 1996, 35: 620-624.PubMedCrossRef
69.
Zurück zum Zitat Ezaki E, Okada M, Yoshikawa Y, Fujikawa Y, Hashimoto M, Otsuka M, Nomura T, Yamamoto K, Watanabe T, Shingu M, Nobunaga M: Human monoclonal rheumatoid factors augment arthritis in mice by the activation of T-cells. Clin Exp Immunol. 1996, 104: 474-482. 10.1046/j.1365-2249.1996.55764.x.PubMedPubMedCentralCrossRef Ezaki E, Okada M, Yoshikawa Y, Fujikawa Y, Hashimoto M, Otsuka M, Nomura T, Yamamoto K, Watanabe T, Shingu M, Nobunaga M: Human monoclonal rheumatoid factors augment arthritis in mice by the activation of T-cells. Clin Exp Immunol. 1996, 104: 474-482. 10.1046/j.1365-2249.1996.55764.x.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Breitner S, Störkel S, Reichel W, Loos M: Complement components C1q, C1r/C1s and C1INH in rheumatoid arthritis. Arthritis Rheum. 1995, 38: 492-498.PubMedCrossRef Breitner S, Störkel S, Reichel W, Loos M: Complement components C1q, C1r/C1s and C1INH in rheumatoid arthritis. Arthritis Rheum. 1995, 38: 492-498.PubMedCrossRef
71.
Zurück zum Zitat Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS: Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984, 59: 737-743.PubMedCrossRef Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS: Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984, 59: 737-743.PubMedCrossRef
72.
Zurück zum Zitat Staines NA, Wooley PH: Collagen arthritis – what can it teach us?. Br J Rheumatol. 1994, 33: 798-807.PubMedCrossRef Staines NA, Wooley PH: Collagen arthritis – what can it teach us?. Br J Rheumatol. 1994, 33: 798-807.PubMedCrossRef
Metadaten
Titel
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
verfasst von
Martinus AM van Boekel
Erik R Vossenaar
Frank HJ van den Hoogen
Walther J van Venrooij
Publikationsdatum
01.11.2001
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 2/2001
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar395

Weitere Artikel der Ausgabe 2/2001

Arthritis Research & Therapy 2/2001 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.